Status:

COMPLETED

FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)

Lead Sponsor:

United Therapeutics

Conditions:

Pulmonary Hypertension

Eligibility:

All Genders

12-70 years

Phase:

PHASE3

Brief Summary

This study was an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who were currently receiving approved therapy for their PAH (i.e., endothelin rec...

Eligibility Criteria

Inclusion

  • Between 12 and 70 years of age, inclusive.
  • Body weight at least 45 kg (approximately 100 pounds).
  • PAH that is either idiopathic/heritable (including PAH associated with appetite suppressant/toxin use); PAH associated with repaired congenital systemic-to-pulmonary shunts (repaired ≥ 5 years); PAH associated with collagen vascular disease; or PAH associated with HIV.
  • Baseline 6-minute walk distance between 150 and 450 meters, inclusive.
  • Currently receiving an approved endothelin receptor antagonist and/or an approved phosphodiesterase-5 inhibitor for at least 90 days and on a stable dose for at least the last 30 days.
  • Previous testing (e.g., right heart catheterization, echocardiography) consistent with the diagnosis of PAH.
  • Reliable and cooperative with protocol requirements.

Exclusion

  • Nursing or pregnant.
  • Received a prostacyclin within the past 30 days.
  • PAH due to conditions other than noted in the above inclusion criteria.
  • History of uncontrolled sleep apnea, renal insufficiency, anemia, left sided heart disease, uncontrolled systemic hypertension, or parenchymal lung disease.
  • Use of an investigational drug within 30 days of Baseline.

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

354 Patients enrolled

Trial Details

Trial ID

NCT00325442

Start Date

October 1 2006

End Date

December 1 2010

Last Update

August 2 2017

Active Locations (72)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 18 (72 locations)

1

University of Alabama-Birmingham

Birmingham, Alabama, United States, 35294

2

Arizona Pulmonary Specialist

Phoenix, Arizona, United States, 85013

3

University of Arizona Health Science Center

Tucson, Arizona, United States, 85724

4

West Los Angeles VA Healthcare Center

Los Angeles, California, United States, 90073